Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company that develops cell therapy platforms for cancer patients. Its portfolio includes CD38-GEAR-NK for CD38-related cancers such as multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged tumor-specific antibodies to potentially target various tumor types including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to assess suitability for anti-CD38 mAb therapy. The company collaborates with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease, and with Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for Parkinson's disease. It is headquartered in Wexford, Pennsylvania.